Journals / MN Kardiyoloji / 2002 / Cilt: 9 - Sayı: 1

Effect of hormone replacement therapy on QT and rate adjusted QT dispersiyon on rest and peak exercise ECG in postmenopausal women

Menapoza giren kadınlarda uzun süreli hormon replasman tedavisinin istirahat ve zirve egzersiz elektrokardiografideki QT ve hıza göre düzeltilmiş QT dispersiyonuna etkisi

Pages
19–22
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

CONCLUSION: Long term HRT, consisting of estrogen + progestin, don't affect the resting QT parameters, whereas it leads to increase in QT and corrected to heart rate QT dispersion at peak exercise.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:AIM: It is known that QT interval is more longer in women than male.
📊
Key Findings & Data:MATERIAL AND METHODS: We compared QT parameters obtained from surface electrocardiogram at resting and peak exercise in before and 6 months after HRT consisting of estrogen + progestin in healthy postmenopausal women.
💡
Conclusion & Impact:CONCLUSION: Long term HRT, consisting of estrogen + progestin, don't affect the resting QT parameters, whereas it leads to increase in QT and corrected to heart rate QT dispersion at peak exercise.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Uzun QT sendromu · Postmenopoz · Elektrokardiyografi

Abstract

AIM: It is known that QT interval is more longer in women than male. Estrogen is accused from QT interval prolongation in several studies which conducted with hormone replacement therapy (HRT) in postmenopausal women. Along with this, it is conflict study data as regards the effects of HRT on QT interval and dispersion. Moreover, there is not knowledge about the effect of HRT on exercise QT parameters. MATERIAL AND METHODS: We compared QT parameters obtained from surface electrocardiogram at resting and peak exercise in before and 6 months after HRT consisting of estrogen + progestin in healthy postmenopausal women. To aim this, 24 healthy postmenopausal women were given 0.625 mg/day conjugated estrogens and 2.5 mg/day medroxyprogesteron acetate for 6 months. Exercise stress testing using the Bruce protocol was performed before and after HRT. QT maximum, minimum, dispersion and corrected to heart rate QT maximum, minimum and dispersion were calculated at resting and peak exercise. RESULTS: HRT resulted in a significant increase in estradiol plasma levels from 24±10 pg/mL to 117±66 pg/mL (p<0.001). It was not observed a significant difference on resting QT parameters after HRT, whereas it was detected that QT and corrected to heart rate QT dispersion significantly increased at peak exercise (20±7 versus 25±10 ms; p<0.05, 33±12 versus 41±16 ms; p<0.05, respectively). Nonetheless, the other exercise QT parameters were unchanged. CONCLUSION: Long term HRT, consisting of estrogen + progestin, don't affect the resting QT parameters, whereas it leads to increase in QT and corrected to heart rate QT dispersion at peak exercise.

Özet

AMAÇ: Kadınlarda QT süresinin erkeklere göre daha uzun olduğu bilinmektedir. Postmenapozal kadınlarda hormon replasman tedavisi (HRT) ile yapılan bazı çalışmalarda QT uzamasından sorumlu olarak östrojen suçlanmıştır. Bununla birlikte, HRT'nin QT süresi ve QT dispersiyonu üzerine etkileri ile ilgili çalışma sonuçları çelişkilidir. Ayrıca HRT'nin egzersiz QT parametrelerine etkisiyle ilgili bilgi yoktur. GEREÇ VE YÖNTEM: Postmenapozal sağlıklı kadınlarda östrojen + progesteron ile HRT öncesi ve 6 ay sonrasında istirahat ve zirve egzersizde yüzey elektrokardiyogramdan elde edilen QT parametrelerini karşılaştırdık. Bu amaçla 24 sağlıklı postmenapozal kadına 0.625 mg konjuge östrojen/gün ve 2.5 mg medroksiprogesteron asetat/gün ile HRT uygulandı ve 6 ay süreyle devam edildi. Tedavi öncesi ve sonrasında Bruce protokolüne göre egzersiz stres testi uygulandı. İstirahat ve zirve egzersizde QT maksimum, minimum, dispersiyon ve hıza göre düzeltilmiş QT maksimum, minimum ve dispersiyon hesaplandı. BULGULAR: HRT sonrası östrojen seviyesinin önemli olarak arttığı görüldü (24±10 pg/ml'ye karşın 117±66, p<0.001). HRT sonrası istirahat QT parametrelerinde bir değişiklik gözlenmezken, zirve egzersizde QT ve hıza göre düzeltilmiş QT dispersiyonun önemli derecede arttığı tespit edildi (Sırasıyla, 20±7'ye karşın 25±10 msn; p<0.05, 33±12'ye karşın 41±16msn; p<0.05). Diğer egzersiz QT parametreleri ise değişmedi. SONUÇ: Uzun süreli östrojen + progesteron ile yapılan HRT, istirahat QT parametrelerini etkilemezken, zirve egzersiz QT ve hıza göre düzeltilmiş QT dispersiyonunda artışa yol açar.

🔖

Cite This Article

ALTUNKESER, B. B., ÖZDEMİR, K., İÇLİ, A., ÇELİK, Ç., AKYÜREK, C., GÖK, H. (2002). Effect of hormone replacement therapy on QT and rate adjusted QT dispersiyon on rest and peak exercise ECG in postmenopausal women. MN Kardiyoloji, Cilt: 9 - Sayı: 1, 19–22. https://ajindex.com/articles/297720

References (15)

  1. Mirvis DM. Spatial variation of QT intervals in normal persons and patients with acute myocardial infarction. J Am Coll Cardiol 1985; 5:625-31.
  2. Higham PD, Campbell RWF. QT dispersion. Br Heart J 1994; 71:508-10.
  3. Han J, Goel BG. Electrophysiologic precursors of ventricular tachyarrhythmias. Arch Intern Med 1972; 129:749-55.
  4. Merx W, Yoon MS, Han J. The role of local disparity in conduction and recovery time on ventricular vulnerability to fibrillation. Am Heart J 1977; 94:603-10.
  5. Kuo CS, Munakata K, Reddy CP, Surawicz B. Characteristics and possible mechanism of ventricular arrhythmia dependent on the dispersion of action potential durations. Circulation 1983; 67:1356- 67. Yunus A, Gillis AM, Duff HJ, Wyse DG, Mitchell LB. Increased precordial QTc dispersion predicts ventricular fibrillation during acute myocardial infarction. Am J Cardiol 1996; 78:706-8.
  6. Lehman MH, Hardy S, Archibald D, Quart B, MacNeil DJ. Sex difference in risk of torsades de pointes with d,l- sotalol. Circulation 1996:94:2534-41.
  7. Makkar RR, Fromm BS, Steinman RT, Meissner MD, Lehman MH. Female gender as a risk factor for torsades de pointes associated with cardiovascular drugs. JAMA 1993; 270:2590-7.
  8. Kawasaki R, Machado C, Reinoehl J, Fromm B, Baga JJ, Steinman RT, Lehman MH. Increased propensity of women to develop torsades de pointes during complete heart block. J Cardiovasc Electrophysiol 1995; 6:1032-8.
  9. Gimeno AL, Gimeno MF, Webb JL. Actions of sex steroids on the eletrical and mechanical properties of rat atrium. Am J Physiol 1963; 205:198-200.
  10. Prinzmetal M, Ishikawa K, Nakashima M, Oisha H, Özkan E, Wakayama J, Baines JM. Estrogens and the heart. Am J Obst Gynec 1967; 98:575-6.
  11. Pragnell M, Snay KJ, Trimmer JS, MacLusky NJ, Naftolin F, Kaczmarek LK, Boyle MB. Estrogen induction of a small, putative K+ channel mRNA in rat uterus. Neuron 1990; 4:807-12.
  12. Drici MD, Burklow TR, Haridasse V, Glazer Rl, Woosley RL Sex hormones prolong the QT interval and downregulate potassium channel expression in the rabbit heart. Circulation 1996; 94:1471-4.
  13. Larsen JA, Tung RH, Sadananda R, Goldberger JJ, Horvath G, Parker MA, Kadish AH. Effects of hormone replacement therapy on QT interval. Am J Cardiol 1998; 82:993-5.
  14. Sbarouni E, Zarvalis E, Kyriakides ZS, Kremastinos DT. Absence of effects of short-term estrogen replacement therapy on resting and exertional QT and QTc dispersion in postmenopausal women with coronary artery disease. PACE 1998; 21:2392-5.
  15. Saba S, Link M, Homoud MK, Wang PJ, Estes III N